IMPEL PHARMACEUTICALS INC (IMPL)

US45258K1097 - Common Stock

0.2411  -0.17 (-41.79%)

After market: 0.22 -0.02 (-8.75%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2023-6-30)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
19.04M12.65M670.00K0.000.00
Cost Of Goods
8.14M6.40M690.00KN/AN/A
Gross Profit
10.91M6.26M-20.00KN/AN/A
Operating Expenses
88.35M89.34M71.46M45.33M41.57M
Research and Development
7.10M11.46M20.56M27.29M28.81M
Selling, General, and Administrative Expenses
81.30M77.89M50.90M18.05M12.75M
Operating Income
-77.44M-83.08M-71.49M-45.33M-41.57M
Interest Income/Expense
-11.91M-13.84M-2.20M-60.00K420.00K
Other Income/Expense
360.00K-5.99M-850.00K-410.00K-680.00K
Non Recurring Items
-2.58M-3.40M-2.00MN/AN/A
Income Before Taxes
-91.57M-106.31M-76.53M-45.80M-41.83M
Income Tax
0.000.000.000.0030.00K
Net Income
-91.57M-106.31M-76.67M-46.32M-42.36M
EBITDA
-76.62M-81.88M-70.40M-44.25M-40.85M
 
Per Share Data
EPS Diluted Total Ops
-3.86-4.53-5.25-2.39-2.18
Non GAAP EPS
-4.41-4.54-3.95N/AN/A
 
Statistics
Gross Profit Margin
57.30%49.49%-2.99%N/AN/A
Profit Margin
-480.93%-840.40%-11443.28%N/AN/A
Operating Profit Margin
-406.72%-656.76%-10670.15%N/AN/A

All data in USD

Charts